NCT00953472View on ClinicalTrials.gov

B-type Natriuretic Peptide (BNP) in Human Hypertension

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Hypertension Stage 1
Interventions
DRUG

brain natriuretic peptide

start 10 mcg/kg (2 participants), 7 mcg/kg (2 participants), 5 mcg/kg (2 participants) and 2 mcg/kg (2 participants)

OTHER

no-added salt diet

instruction to reduce salt for one week prior to study

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER